You are here

Sanofi

FDA fast-tracks Sanofi's experimental chlamydia vaccine

Pharmaphorum

Thu, 03/27/25 - 11:05 am

FDA starts review of Sanofi's MS hope tolebrutinib

Pharmaphorum

Tue, 03/25/25 - 10:20 am

multiple sclerosis

Sanofi to acquire Dren Bio’s immunology unit

Investing.com

Thu, 03/20/25 - 11:25 am

autoimmune diseases

Lilly, J&J, Pfizer and Sanofi back Teva fight against IRA drug negotiation program

Fierce Pharma

Tue, 03/18/25 - 11:00 pm

Teva Pharmaceutical

Inflation Reduction Act

Sanofi adopts FDA-selected flu strains to ensure readiness for the 2025-26 flu season

Stock Titan

Sun, 03/16/25 - 09:59 pm

Sanofi bounces midstage ILT2 asset back to Biond Biologics after $125M bet

Fierce Biotech

Mon, 03/3/25 - 11:50 pm

Biond Biologics

monoclonal antibodies

Alopexx seeks $11M IPO to advance ex-Sanofi infectious disease drug

Fierce Biotech

Wed, 02/26/25 - 10:53 am

Sanofi shows how $500M bowel disease bet compares to Merck and Roche's rival assets

Fierce Biotech

Mon, 02/24/25 - 11:32 am

Teva Pharmaceutical

clinical trials

inflammatory bowel disease

First biosimilar fast-acting insulin reaches US market

Pharmaphorum

Tue, 02/18/25 - 09:47 am

Sanofi, J&J abandon trial of E coli vaccine after poor data

Pharmaphorum

Thu, 02/13/25 - 11:38 am

clinical trials

Regeneron tangles with Sanofi over commercial transparency in long-running Dupixent collaboration

Fierce Pharma

Thu, 02/6/25 - 10:50 pm

Drugmakers prep for bird flu outbreak, despite continued low risk

Pharma Voice

Mon, 02/3/25 - 11:43 am

Sanofi Plans €5 Billion Buyback, Sees Higher Profit Growth

Yahoo/Bloomberg

Thu, 01/30/25 - 10:55 am

Sanofi API plant hit with FDA warning letter detailing quality, consistency flubs

Fierce Pharma

Tue, 01/21/25 - 07:08 pm

drug manufacturing

Could OTC Cialis for erectile dysfunction reach the US?

Pharmaphorum

Tue, 01/21/25 - 11:11 am

consumer healthcare

erectile dysfunction

Sanofi to increase competition in atopic dermatitis market after Dupixent success

Clinical Trials Arena

Thu, 01/16/25 - 11:09 am

Kymera Therapeutics

atopic dermatitis

JPM25: GSK, Sanofi CEOs welcome 'transparency' in response to anti-vaccine movement in US

Fierce Pharma

Tue, 01/14/25 - 06:21 pm

Sanofi scores with its subcutaneous version of Sarclisa as it tries to play catch up with J&J's Darzalex

Fierce Pharma

Thu, 01/9/25 - 11:55 am

Multiple Myeloma

LB Pharma's twist on old Sanofi drug passes schizophrenia test, teeing up phase 3 push

Fierce Biotech

Wed, 01/8/25 - 11:19 am

clinical trials

5 FDA decisions to watch in the first quarter of 2025

BioPharma Dive

Mon, 01/6/25 - 06:54 pm

Vertex Pharmaceuticals

non-opioid pain treatments

transthyretin amyloid cardiomyopathy

diazoxide choline

Prader Willi syndrome

Pages